Maze Therapeutics Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Maze Therapeutics stock have an average target of 25.67, with a low estimate of 19 and a high estimate of 30. The average target predicts an increase of 127.17% from the current stock price of 11.30.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$19	$25.67	$28	$30
Change	+68.14%	+127.17%	+147.79%	+165.49%

Analyst Ratings

The average analyst rating for Maze Therapeutics stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Mar '25
Strong Buy	1
Buy	2
Hold	0
Sell	0
Strong Sell	0
Total	3

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Debjit Chattopadhyay Guggenheim	Guggenheim	Strong Buy Initiates $19	Strong Buy	Initiates	$19	+68.14%	Feb 25, 2025
Joseph Schwartz Leerink Partners	Leerink Partners	Buy Initiates $28	Buy	Initiates	$28	+147.79%	Feb 25, 2025
Anupam Rama JP Morgan	JP Morgan	Buy Initiates $30	Buy	Initiates	$30	+165.49%	Feb 25, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

n/a

EPS Next Year

n/a

No financial forecasts available for this stock

Revenue Forecast

No data available

Revenue Growth

No data available

EPS Forecast

No data available

EPS Growth

No data available

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.